🧩
Free audit · No signup
Tool Sprawl Risk Audit — Pharmaceuticals
Find out how much spreadsheet and SaaS sprawl is costing Pharmaceuticals — and where a purpose-built internal tool pays off.
Signs of tool sprawl in Pharmaceuticals
- Clinical trial recruitment runs 30-50% behind plan; site activation takes 8-12 months and patient screening is manual chart review.
- Regulatory submissions (NDA, BLA, MAA) are coordinated across dozens of CROs, sites, and writers via SharePoint and version-numbered Word documents.
- Pharmacovigilance case intake is drowning in adverse-event reports; medical reviewers spend nights triaging individual case safety reports.
- GxP validation requirements turn every IT change into a six-month project; cloud and SaaS adoption lags every other regulated industry.
Section 1 of 4 · Source of Truth0/8 answered
Source of Truth
Whether your operational data lives in one place or is scattered across tools.
Ran the numbers? Let’s act on them.
Send us the result and the constraint behind it. We’ll scope the diagnostic, sprint, or build that fixes what the score reveals.